Multi-Tiered Risk Stratification Model for MM May Perform Better Than Standard Systems
March 18th 2022Risk stratification is a difficult process for multiple myeloma (MM), and authors concluded that their multi-tiered model may provide a greater risk assessment benefit than standard stratification systems.
Read More
Treadmill Training Beneficial for Patients With Parkinson Disease
March 18th 2022This review sought to give more information about the types of treadmill training that might be beneficial for patients with Parkinson disease and other neurological disorders engaged in physical rehabilitation programs.
Read More
Study Finds C difficile Infection Manageable in Primary Care Settings With Specialist Guidance
March 17th 2022Cases of Clostridioides difficile (C diff) have increasingly been reported outside of typical settings, and a survey of general practitioners in France found that many cases can be managed without hospitalization.
Read More
Ben Jones Discusses Federal-, State-Level Policies to Promote Value-Based Community Oncology Care
March 17th 2022Ben Jones, vice president, Government Relations & Public Policy, The US Oncology Network, addresses potential reform at the federal and state level that could accelerate the pursuit of value-based care in the community oncology setting.
Watch
Dr Michael Diaz on the Importance of Site of Care, PBM Reform
March 17th 2022Michael Diaz, MD, president and managing physician, Florida Cancer Specialists & Research Institute, speaks on takeaways from his discussions on site of care and pharmacy benefit managers (PBMs) at the 2022 Community Oncology Conference.
Watch
Dr Robert Sidbury Addresses Quality-of-Life Burden in Atopic Dermatitis
March 17th 2022Along with common symptoms of itch and pain, patients with atopic dermatitis experience significant work productivity and attention issues that affect overall quality of life, said Robert Sidbury, MD, MPH, chief, Division of Dermatology, Seattle Children's Hospital.
Watch
What We’re Reading: FFS Medicare Savings; ICU Triage Discrimination; Pfizer, Moderna Patent Lawsuits
March 17th 2022Medicare Advantage plan members could save $12 billion if enrolled in fee-for-service (FFS) plans instead; Black patients were classified as low priority for intensive care unit (ICU) triage twice as often as other patients; Moderna and Pfizer face lawsuits over potential COVID-19 vaccine patent infringement.
Read More
Pfizer and BioNTech requested FDA emergency use authorization for a fourth COVID-19 dose for older adults; postpartum depression rates tripled during early months of the COVID-19 pandemic; anxiety and depression diagnoses among children each increased by roughly 25% since 2016.
Read More
AstraZeneca Receives CRL for Benralizumab in Chronic Rhinosinusitis With Nasal Polyps
March 16th 2022FDA issued a complete response letter (CRL) to AstraZeneca seeking additional clinical data for benralizumab, sold as Fasenra, in the treatment of patients with inadequately controlled chronic rhinosinusitis with nasal polyps.
Read More
Genetic RA Associated With Inflammatory Bowel Disease, but Not Other Way Around
March 16th 2022The genetically-predicted risk of rheumatoid arthritis (RA) was positively associated with an increased risk of inflammatory bowel disease (IBD) and potentially with its main subtypes, ulcerative colitis and Crohn disease.
Read More
More, Better Linkage to Care Needed to Optimize HIV-Related Support Outcomes
March 15th 2022This new meta-analysis from World Health Organization and University of Cape Town investigators analyzed adverse posthospitalization discharge outcomes and related risk factors among persons living with HIV.
Read More
Finerenone Reduces Heart Failure Risk in Patients With CKD, T2D
March 15th 2022Finerenone (Kerendia) was found to reduce risk of heart failure and improve other cardiovascular outcomes in patients with chronic kidney disease (CKD) and type 2 diabetes (T2D) regardless of heart failure history.
Read More